ONCS - OncoSec Medical Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
7/30/2019
7/30/2018
7/30/2017
7/30/2016
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
20,562
18,445
17,416
11,953
14,742
Selling General and Administrative
14,936
11,971
18,690
9,496
12,144
Total Operating Expenses
35,498
30,417
36,105
21,448
26,886
Operating Income or Loss
-35,498
-30,417
-36,105
-21,448
-26,886
Interest Expense
-
4
-
-
-
Total Other Income/Expenses Net
297
146
-3,030
0
0
Income Before Tax
-35,202
-30,275
-39,136
-21,448
-26,886
Income Tax Expense
11
1
1
1
2
Income from Continuing Operations
-35,213
-30,276
-39,136
-21,450
-26,889
Net Income
-35,213
-30,276
-39,136
-21,450
-26,889
Net Income available to common shareholders
-35,213
-30,276
-39,136
-21,450
-26,889
Reported EPS
Basic
-
-
-9.80
-10.60
-16.30
Diluted
-
-
-9.80
-10.60
-16.30
Weighted average shares outstanding
Basic
-
-
4,012
2,019
1,651
Diluted
-
-
4,012
2,019
1,651
EBITDA
-
-30,027
-35,771
-21,068
-26,530